Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemigliptin vs Acarbose for Endothelial Function in T2DM
NCT02500329Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gemigliptin in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02500329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02500329.